OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,628,249 | +30.9% | 131,842 | -4.3% | 0.00% | +33.3% |
| Q2 2023 | $1,243,467 | +122.0% | 137,704 | -14.7% | 0.00% | +50.0% |
| Q1 2023 | $560,173 | +24.1% | 161,433 | -12.4% | 0.00% | +100.0% |
| Q4 2022 | $451,466 | -44.0% | 184,272 | -36.9% | 0.00% | -66.7% |
| Q3 2022 | $806,000 | -37.6% | 291,970 | -7.9% | 0.00% | -25.0% |
| Q2 2022 | $1,291,000 | -49.0% | 317,156 | -46.6% | 0.00% | -42.9% |
| Q1 2022 | $2,532,000 | -56.7% | 594,343 | -4.8% | 0.01% | -41.7% |
| Q4 2021 | $5,843,000 | +113.1% | 624,300 | +527.4% | 0.01% | +100.0% |
| Q3 2021 | $2,742,000 | – | 99,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |